Apparently demonstrating 94% efficacy, the NIH-Moderna vaccine was authorised by the US Food and Drug Administration (FDA) under EUA (Emergency Use Authorisation).
Just days earlier, the similar Pfizer/BioNTech vaccine had also been authorised under EUA.